期刊
BIOMED RESEARCH INTERNATIONAL
卷 2017, 期 -, 页码 -出版社
HINDAWI LTD
DOI: 10.1155/2017/5813793
关键词
-
资金
- National Funds (FCT/MEC, Fundacao para a Ciencia e Tecnologia and Ministerio da Educacao e Ciencia) [PT2020 UID/MULTI/04378/2013-POCI/01/0145/FEDER/007728]
- FCT (Fundacao para a Ciencia e Tecnologia) from International Doctoral Programme on Cellular and Molecular Biotechnology Applied to Health Sciences (BiotechHealth) [PD/BI/128352/2017]
- POPH (Programa Operacional Potencial Humano) [SFRH/BPD/99124/2013]
- European Union (FEDER funds)
- FCT (Fundacao para a Ciencia e Tecnologia)
- [NORTE-01-0145-FEDER-000011]
- Fundação para a Ciência e a Tecnologia [SFRH/BPD/99124/2013, PD/BI/128352/2017] Funding Source: FCT
Nowadays, the society is facing a large health problem with the rising of new diseases, including cancer, heart diseases, diabetes, neurodegenerative diseases, and obesity. Thus, it is important to invest in substances that enhance the health of the population. In this context, epigallocatechin gallate (EGCG) is a flavonoid found in many plants, especially in tea. Several studies support the notion that EGCG has several benefits in fighting cancer, heart diseases, diabetes, and obesity, among others. Nevertheless, the poor intestinal absorbance and instability of EGCG constitute the main drawback to use this molecule in prevention and therapy. The encapsulation of EGCG in nanocarriers leads to its enhanced stability and higher therapeutic effects. A comprehensive review of studies currently available on the encapsulation of EGCG by means of nanocarriers will be addressed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据